Loading…

An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV ( Kinrix ™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children

Highlights ► This study evaluated co-administration of DTaP–IPV and MMR with varicella vaccine in 4–6 year olds. ► Varicella vaccine with DTaP–IPV and MMR did not impact immunogenicity of DTaP–IPV. ► Co-administration of varicella vaccine with DTaP–IPV and MMR was well tolerated. ► Results support c...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2012-01, Vol.30 (3), p.668-674
Main Authors: Klein, Nicola P, Weston, Wayde M, Kuriyakose, Sherine, Kolhe, Devayani, Howe, Barbara, Friedland, Leonard R, Van Der Meeren, Olivier
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► This study evaluated co-administration of DTaP–IPV and MMR with varicella vaccine in 4–6 year olds. ► Varicella vaccine with DTaP–IPV and MMR did not impact immunogenicity of DTaP–IPV. ► Co-administration of varicella vaccine with DTaP–IPV and MMR was well tolerated. ► Results support co-administration of DTaP–IPV, MMR, and varicella vaccines in 4–6-year-olds.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2011.10.065